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Abstract
Leydig cell tumors (LCT) are the most common type of testicular stromal tumor. Herein, we investigate the G protein-coupled
estrogen receptor (GPER) and peroxisome proliferator–activated receptor (PPAR) implication in regulation of lipid homeostasis
including the expression of steroidogenesis-controlling molecules in clinical specimens of LCTs and tumor Leydig cells (MA-
10). We showed the general structure and morphology of LCTs by scanning electron and light microscopy. In LCTs, mRNA and
protein analyses revealed increased expression of GPER and decreased expression of PPARα, β, and γ. Concomitantly, changes
in expression pattern of the lutropin receptor (LHR), protein kinase A (PKA), perilipin (PLIN), hormone sensitive lipase (HSL),
steroidogenic acute regulatory protein (StAR), translocator protein (TSPO), HMG-CoA synthase, and reductase (HMGCS,
HMGCR) were observed. Using MA-10 cells treated with GPER and PPAR antagonists (alone and in combination), we
demonstrated GPER-PPAR–mediated control of estradiol secretion via GPER-PPARα and cyclic guanosine monophosphate
(cGMP) concentration via GPER-PPARγ. It is assumed that GPER and PPAR can crosstalk, and this can be altered in LCT,
resulting in a perturbed lipid balance and steroidogenesis. In LCTs, the phosphatidylinositol-3-kinase (PI3K)-Akt-mTOR path-
way was disturbed. Thus, PI3K-Akt-mTORwith cGMP can play a role in LCToutcome and biology including lipid metabolism.
Keywords Gprotein-coupled estrogen receptor . Peroxisomeproliferator–activated receptor .Leydigcell tumor .
Steroidogenesis-controllingmolecules .Ultrastructure
Introduction
Leydig cell tumor (LCT; leydigioma) is the most common
non-germ cell gonadal tumor, accounting for 1–3% of all tes-
ticular tumors in adults and 4–9% in prepubertal children
(Gheorghisan-Galateanu 2014). In recent years, a marked in-
crease in the incidence of LCTs has been observed (14.7% of
all testicular tumors removed). LCTs are usually benign tu-
mors especially in infancy (Bertram et al. 1991), although
local recurrence or metachronous tumors of the contralateral
testis have also been described. Survival after diagnosis of
primary LCTs ranged from 2 months to 17 years (Rich and
Keating 2000). In prepubertal patients, even malignant LCTs
are less likely to metastasize. Patients with LCTs usually have
symptoms of testicular swelling or various endocrinological
disruptions (Lai et al. 2015). Gynecomastia is the main
clinical manifestation in adults, but it may also be clinically
significant in affected children who undergo precocious
puberty (Lejeune et al. 1998). Some cases of LCTs were
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linked with increased plasma estradiol concentrations (Huang
et al. 2013). Moreover, infertility and azoospermia are not an
unusual finding in these patients (Bozzini et al. 2017).
Radical orchiectomy is the current standard of care, but
testis sparing surgery (TSS) (enucleation), in conjunction with
intraoperative frozen section (FSE), has been recently
attempted with promising results (Giacaglia et al. 2000).
Prepubertal individuals and those with smaller tumors that lack
evidence of malignancy are directly recommended for TSS.
The etiology of LCTs is unknown and appears heteroge-
neous. Furthermore, the molecular basis of LCTs is poorly un-
derstood. Some studies showed a possible role of genetic fac-
tors in LCT development. Interestingly, genetic mutations iden-
tified in children and adults were different and, in some cases,
associated with other cancers (Carvajal-Carmona et al. 2006).
In adults, it was observed that a somatic activating mutation in
the guanine nucleotide-binding protein α gene may result in
tumor development, leading to hyperactivity of sex steroid bio-
synthesis (Bertram et al. 1991). In addition, Carvajal-Carmona
et al. (2006) reported an inherited fumarate hydratase mutation
appears to cause tumor growth through activation of the hyp-
oxia pathway. According to study of Lejeune et al. (1998),
alterations in local stimuli, including Müllerian-inhibiting hor-
mone, inhibin, growth factors, and temperature, may also create
favorable conditions for initiation and development of LCTs.
Decreased Leydig cell function is common in men with
reproductive disorders, including testicular dysgenesis syn-
drome (TDS). This syndrome is comprised of subfertility,
cryptorchidism, hypospadias, and testicular cancer
(Skakkebaek et al. 2001). Leydig cell impairment manifests
as a decreased testosterone/lutropin (LH) ratio and the pres-
ence of Leydig cell micronodules in the testis (Holm et al.
2003). The number and size of micronodules increase with
the severity of TDS (Lardone et al. 2013). Due to ultrastruc-
tural changes demonstrated in Leydig cells within
micronodules (decreased smooth endoplasmic reticulum, ir-
regularly indented nuclear membrane, decreased lipofuscin
pigment granules, and Reinke crystals), failure of their matu-
ration is suggested (Soerensen et al. 2016). In patients with
germ cell tumors, Leydig cell hypertrophy and hyperplasia
were linked to elevated levels of chorionic gonadotropin
(Zimmerli and Hedinger 1991). Various chemicals induced
Leydig cell hyperplasia via disruption of the hypothalamic-
pituitary axis (Dirami et al. 1996). Alternatively, an excess
of various hormones (e.g., estrogen, prolactin) produce elevat-
ed LH levels that excessively stimulate steroidogenic Leydig
cell function (Greaves 2012). Overproliferation of Leydig
cells may result in the synthesis of non-functional steroid hor-
mones.Morphologically, no differences appear between spon-
taneous or chemically induced Leydig cell adenomas
(Aoyama et al. 1998). However, there is no evidence as to
whether increase of Leydig cell number may further develop
into malignant Leydig cell tumor (Gould et al. 2007).
Mitogenicity associated with estrogen receptor–mediated
cellular events is believed to be the mechanism by which es-
trogens contribute to tumorigenesis. Currently, implications of
estrogen signaling via canonical estrogen receptors (ERs), G
protein coupled membrane estrogen receptor (GPER), as well
as estrogen-related receptors (ERRs) are recognized in animal
and human Leydig cell tumorigenesis (Carpino et al. 2007; Tazi
et al. 2008; Kotula-Balak et al. 2012, 2018a; Chimento et al.
2014). In human testis, Fietz et al. (2014, 2016) showed high
levels of GPER mRNA expression in Leydig cells. However,
GPER multiple fast signaling pathways are already described
(Prossnitz and Barton 2011); they function is still not entirely
known. Peroxisome proliferator–activated receptor (PPAR) be-
longs to the steroid family receptors and is also able to bind
steroid hormones (Levin 2011). In amphibians, rodents, and
humans, three forms of PPAR have been described to date:
PPARα, PPARβ (also known as PPARδ), and PPARγ
(Schmidt et al. 1992). PPARs target genes that encode enzymes
involved in peroxisome and mitochondria function as well as
those of fatty acids, apolipoproteins, and lipoprotein lipase.
Little is known about PPARs in the male reproductive system.
In rat testis, PPARs are mainly expressed in Leydig and Sertoli
cells (Braissant et al. 1996). It was shown that some PPAR
chemicals alter testosterone production (Harada et al. 2016),
and their long-term administration results in Leydig cell tumor
development in rats (Hess 2003).
Scarce data are available on the molecular and biochemical
characteristics of LCTs. Maintaining an adequate hormonal
balance within the testis is the basis for proper gonadal func-
tion, thus playing a pivotal role for blocking hormone-
secreting Leydig cell tumor development (Seyfried and
Shelton 2010).
It is worth noting that biosynthesis of sex steroids is multi-
level, controlled process (Miller 2013). It requires the
coordinated expression of number of genes, proteins of
various function [receptors, e.g., lutropin receptor (LHR),
enzymes, transporters, and regulators, e.g., translocator
protein (TSPO), steroidogenic acute regulatory protein
(StAR)), signaling molecules (e.g., protein kinase A (PKA)],
and their regulators in response to LH stimulation. Moreover,
for cellular steroidogenic function, global lipid homeostasis is
crucial. Perilipin (PLIN), hormone sensitive lipase (HSL), and
HMG-CoA synthase (HMGCS) as well as reductase
(HMGCR) are members of a cell structural and enzymatic
protein machinery controlling lipid homeostasis (Liu et al.
2012). Activation of lipid metabolism is an early event in
tumorigenesis (Seyfried and Shelton 2010) however, the pre-
cise expression pattern of lipid balance-controlling molecules
and their molecular mechanism remains poorly characterized.
This study aims to determine the potential link between
GPER and PPAR and whether this interaction regulates lipid
homeostasis in LCTs. To further investigate the relationship of
Leydig cell tumorigenesis to these receptors while elucidating
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the effects of their interactions, mouse tumor Leydig cells
(MA-10) were utilized.
Materials and methods
Tissue samples and ethical considerations
Residual tissues from testicular biopsy (microdissection testicular
sperm extraction by Schlegel, 1998) were collected at the nOvum
Fertility Clinic, Warsaw, Poland from patients (31–45 years old;
n= 24) diagnosed due to azoospermia (micronodules LCTs were
recognized during surgery). After evaluation by pathologists, pa-
tient written informed consent according to the approval regula-
tions by theNational Commission of Bioethics at the Jagiellonian
University in Krakow, Poland, permit no. 1072.6120.218.2017
and in accordance with the Declaration of Helsinki specimens
were used for the present study. Remaining tissue fragments were
snap-frozen or fixed and paraffin-embedded and were stored and
analyzed at the Department of Endocrinology, Institute of
Zoology and Biomedical Research, Jagiellonian University in
Krakow, Poland.
Cell culture and treatments
The mouse Leydig cell line MA-10 was a generous gift from
Dr. Mario Ascoli (University of Iowa, Iowa City, USA) and
was maintained under standard technique (Ascoli 1981). The
cells were grown inWaymouth’s media (Gibco, Grand Island,
NY) supplemented with 12% horse serum and 50 mg/l of
gentamicin at 37 °C in 5% CO2. Cells were plated overnight
at a density of 1 × 105 cells/mL per well.
Twenty-four hours before the experiments, the medium
was removed and replaced with a medium without phenol
red supplemented with 5% dextran-coated, charcoal-treated
FBS (5% DC-FBS) to exclude estrogenic effects caused by
the medium. Next, cells were treated with selective antago-
nists: GPER [(3aS*,4R*,9bR*)-4-(6-bromo-1,3-benzodioxol-
5-yl)-3a,4,5,9b-3H-cyclopenta[c]quinolone; G-15] (Tocris
Bioscience, Bristol, UK), PPARα [N-((2S)-2-(((1Z)-1-meth-
yl-3-oxo-3-(4-(trifluoromethyl)phenyl)prop-1-enyl)amino)-
3-(4-(2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy)
phenyl)propyl)propanamide, GW6471], or PPARγ [2-chloro-
5-nitro-N-4-pyridinylbenzamide, T0070907] freshly prepared
as stock solutions in dimethyl sulfoxide (DMSO) (Sigma-
Aldrich) and stored at − 20 °C. Stock concentrations were
subsequently dissolved in Waymouth’s media to a final con-
centration. Cells were treated with G-15, PPARα, or PPARγ
alone or together for 24 h. Doses of G-15 (10 nM), PPARα
(10 μM) or PPARγ (10 μM) (Gorowska-Wojtowicz et al.
2018). Control cells were treated with DMSO (final conc.
0.1%). Cell lysates and culture media were frozen in − 20 °C
for further analyses.
Scanning electron microscopy analysis
LCTs were fixed and processed with the use of Hitachi S-4700
scanning electron microscope (Hitachi, Tokyo, Japan) as pre-
viously described (Pawlicki et al. 2019).
Histology
For routine histology, hematoxylin-eosin staining was per-
formed on 4% paraformaldehyde LCT sections. As a control,
commercially available paraffin sections of human testis (cat.
no. HP-401; Zyagen, San Diego, CA, USA) were used.
RNA isolation, reverse transcription, and real-time
quantitative RT-PCR
Total RNAwas extracted from LCTs specimens and commer-
cially available normal human Leydig cells (cat. no 10HU-
103; ixCells Biotechnologies, San Diego CA, USA) using
TRIzol® reagent (Life Technologies, Gaithersburg, MD,
USA) according to the manufacturer’s instructions. Total
cDNA was prepared using High-Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Carlsbad, CA, USA)
according to the manufacturer’s instructions. Avolume equiv-
alent to 1 μg of total RNA was reverse transcribed. Total
cDNAwas prepared in a 20-μL volume using a random prim-
er, dNTPmix, RNase inhibitor, and reverse transcriptase (RT).
Parallel reactions for each RNA sample were run in the ab-
sence of RT to assess genomic DNA contamination. RNase-
free water was added in place of the RT product.
RT-PCR was performed using the StepOne Real-Time
PCR system (Applied Biosystems) and optimized standard
conditions as described previously by Kotula-Balak et al.
(2013, 2018b). Based on the gene sequences in Ensembl da-
tabase, primer sets were designed using Primer3 software
(Table 1). Selected primers were synthesized by Institute of
Biochemistry and Biophysics, Polish Academy of Sciences
(Warsaw, Poland). To calculate the amplification efficiency,
serial cDNA dilution curves were produced for all genes. A
graph of threshold cycle (Ct) versus log10 relative copy num-
ber of the sample from a dilution series was produced. The
slope of the curve was used to determine the amplification
efficiency: %E = (10–1/slope − 1) × 100. All PCR assays
displayed efficiency between 94 and 104%. Detection of am-
plification gene products was performed with 10 ng cDNA,
0.5 μM primers, and SYBR Green master mix (Applied
Biosystems) in a final volume of 20 μL. Amplifications were
performed as follows: 55 °C for 2 min, 94 °C for 10 min,
followed by annealing temperature for 30 s (Table 1), and
45 s 72 °C to determine the cycle threshold (Ct) for quantita-
tive measurement. To confirm amplification specificity, the
PCR products from each primer pair were subjected tomelting
curve analysis and subsequent agarose gel electrophoresis (not
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shown). Images were captured using a Bio-Rad Gel Doc XR
System (Bio–Rad Laboratories, Hercules, CA, USA) (not
shown). mRNA expression within the control group was ar-
bitrarily set as 1, against which statistical significance of ex-
perimental groups was analyzed. mRNA expressions were
normalized to the β-actin mRNA (relative quantification,
RQ = 1) with the use of the 2−ΔΔCt method.
Western blotting
For quantification of protein expression (Table 2), LCT proteins
(as a control commercially available normal human Leydig
cells; cat. No 10HU-103; ixCells Biotechnologies, San Diego
CA, USA) were extracted in radioimmunoprecipitation assay
buffer (RIPA; Thermo Scientific, Inc. Rockford IL, USA).
Aliquots (50 μg protein) of cell lysates were used for electro-
phoresis on 12% mini gel by standard SDS-PAGE procedures
and electrotransferred to polyvinylidene difluoride (PVDF)
membranes (Millipore Corporate, MA, USA) by a semi-dry
transfer cell (Bio-Rad). Then, blots were blocked with 5%
non-fat dry milk in TBS, 0.1% Tween 20, overnight at 4 °C
with shaking, followed by an incubation with respective anti-
bodies (Table 2).
The membranes were washed and incubated with a second-
ary antibody conjugated with the horseradish-peroxidase la-
beled goat anti-mouse or goat anti-rabbit IgGs (Vector Labs.,
Burlingame, CA, USA) at a dilution 1:1000, for 1 h at RT.
Immunoreactive proteins were detected by chemilumines-
cence with Western Blotting Luminol Reagent (Santa Cruz
Biotechnology), and images were captured with a
ChemiDoc XRS + System (Bio-Rad Laboratories). All immu-
noblots were stripped with stripping buffer containing
62.5 mM Tris–HCl, 100 mM 2-mercaptoethanol, and 2%
SDS (pH 6.7) at 50 °C for 30 min and incubated in a mouse
monoclonal antibody against β-actin. Each data point was
normalized against its corresponding β-actin data point.
Quantitative analysis was performed for three separately
repeated experiments using a public domain ImageJ software
Table 1 Sequences of forward













































GPER G-coupled estrogen receptor, PPARα peroxisome proliferator–activated receptor alpha, PPARβ peroxi-
some proliferator–activated receptor beta, PPARγ peroxisome proliferator–activated receptor gamma, LHR lutro-
pin receptor, PKA c.s. α protein kinase catalytic subunit alpha, PLIN1 perilipin 1, HSL hormone sensitive lipase,
StAR steroidogenic acute regulatory protein, TSPO translocator protein, HMGCS 3-hydroxy-3-methylglutaryl-
CoA synthase 1, HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase, β-actin beta-actin
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(National Institutes of Health, Bethesda, MD) as described
elsewhere (Smolen 1999). Protein level within the control
group was arbitrarily set as 1, against which statistical signif-
icance of experimental groups was analyzed. The relative pro-
tein levels were expressed as arbitrary units.
Immunohistochemistry
To optimize immunohistochemical staining testis sections,
both commercially available control (Zyagen, San Diego,
CA, USA) and LCT sections were immersed in 10 mM citrate
buffer (pH 6.0) and heated in a microwave oven (2 × 5 min,
700 W). After overnight incubation at 4 °C with primary an-
tibodies, (they are listed in Table 2) respective biotinylated
antibodies (anti-rabbit and anti-mouse IgGs; 1: 400; Vector,
Burlingame CA, USA) and avidin-biotinylated horseradish
peroxidase complex (ABC/HRP; 1:100; Dako, Glostrup,
Denmark) were applied in succession. Bound antibody was
visualized with 3,3′-diaminobenzidine (DAB) (0.05%; v/v;
Sigma-Aldrich) as a chromogenic substrate. Control sections
included omission of primary antibody and substitution by
irrelevant IgG (Bilinska et al. 2018).
Table 2 Primary antibodies used
for immunohistochemistry and
Western blot

















































PI3Kp85 Rabbit Cell Signaling Technology
cat. no. 4292
1:500 (WB)
t-Akt Rabbit Cell Signaling Technology
cat. no. 9272S
1:1000 (WB)






GPER G-coupled estrogen receptor, PPARα peroxisome proliferator–activated receptor alpha, PPARβ peroxi-
some proliferator–activated receptor beta, PPARγ peroxisome proliferator–activated receptor gamma, LHR lutro-
pin receptor, PKA c.s. α protein kinase catalytic subunit alpha, PLIN1 perilipin 1, HSL hormone sensitive lipase,
StAR steroidogenic acute regulatory protein, TSPO translocator protein, HMGCS 3-hydroxy-3-methylglutaryl-
CoA synthase 1, HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase, PI3K phosphatidylinositol-45-
bisphosphate 3-kinase, t-Akt Akt-serine/threonine-specific protein kinase (protein kinase B), mTOR the mamma-
lian target of rapamycin kinase
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cGMP concentration and estradiol secretion
The production of cGMP in control and treated with GPER
and PPAR antagonists (alone or in combinations) MA-10 cells
was measured by General Cyclic guanosine monophosphate
ELISA kit assay (EIAab Wuhan Eiaab Science Co., LTD,
Wuhan, China) according to the manufacturer’s instructions
with detection level 0.31 to 20.0 ng/mL. The cGMP levels
were calculated as nanograms per milliliter.
Estradiol Enzyme Immunoassay Kit (DRG, Inc. Int.
Springfield, USA) was used for measurement of estradiol con-
tent in culture medium from control and treated with GPER
and PPAR antagonists (alone or in combinations) MA-10 cells
according to the manufacturer’s instructions. The sensitivity
of the assay was 10.6 pg/mL. The absorbance (λ = 450 nm)
was measured. Data were expressed as mean ± SD.
The measurements were performed with the use ELISA
apparatus (Labtech LT-4500).
Statistics
Three biological repeats of each sample (n = 7) and three in-
dependent experiments were performed. Each variable was
tested using the Shapiro-Wilk W test for normality. The ho-
mogeneity of variance was assessed with Levene’s test.
Comparisons were performed by one-way ANOVA, followed
by Dunnett’s post hoc test (GB-STAT software, v. 7.0;
Dynamic Microsystems) to determine the significant differ-
ences between proteins expression levels, cGMP content,
and estradiol secretion. Statistical analyses were performed
on raw data using Statistica 10 software (StatSoft Inc.,
Tulsa, OK, USA). Data were presented as means ± S.D.
Data were considered statistically significant at ∗p < 0.05,
∗∗p < 0.01, and ∗∗∗p < 0.001.
Results
Scanning electron microscopic and morphological
observations of LCTs
Scanning electron microscopy analyses of LCT biopsy frag-
ments (Fig. 1 A–D) revealed the tumors were relatively com-
pact structures of oval or slightly elongated shape (Fig. 1 A–
C) with tumor cells apposed and tightly adhering to one an-
other (Fig. 1 E, F).
It is important to note that some tumor cells were fused. In
addition, compact areas of tumor cells were separated by deep
grooves. Between those grooves, compact tumor sheets were
formed (Fig. 1 E–G). Cells within sheets were compactly linked
by thick projections and masses of such connections were ob-
served between cells from neighboring tumor sheets (Fig. 1 E,
F). Higher magnification revealed the presence of elongated,
delicate filiform fibrillar projections that formed a cage-like
structure covering individual tumor sheets (Fig. 1 I–L).
Hematoxylin-eosin staining demonstrated a mixture of four
morphological types of cells in the tumor mass when com-
pared to controls, where single or small groups of Leydig cells
were seen in the interstitial space (Fig. 2 A, B).
In LCTs, most cells possessed a large polygonal shape with
abundant cytoplasm, indistinct cell borders, and regular round
to oval nuclei. The nucleus was found to be frequently prom-
inent (Fig. 2 b). Occasionally, cells as those noted above were
found to possess distinct cell borders and smaller nuclei (Fig.
2 b’). Small cells with scant, densely eosinophilic cytoplasm
and a grooved nucleus (Fig. 2 b”) and spindle-shaped
(sarcomatoid) cells (Fig. 2 b”’) were observed as well.
Expression and localization of GPER and PPARs
in LCTs
In LCTs, increased expression of GPER (p < 0.05) and de-
creased expression of PPARα (p < 0.001), PPARβ
(p < 0.01), and PPARγ (p < 0.001) were seen when compared
to controls (Fig. 3 a, b). Corresponding to GPER and PPAR
protein expressions, changes in their mRNA expressions in
LCTs were found (Fig. 3).
No changes in GPER localization and staining intensity
were found in control Leydig cells and LCTs (Fig. 4 a, a’).
Specifically, the staining was exclusively cytoplasmic and of
moderate intensity. Localization and immunostaining intensity
of PPAR varied between Leydig cells of control testis and LCTs
(Fig. 4 b, b’, c, c’, d, d’). While strong cytoplasmic-nuclear
expression of PPARα, β, and γ was found in control samples,
weak PPARα immunoexpression and moderate-to-very weak
expression of PPARβ and PPARγ, respectively, were detected.
In LCTs, PPARs were located primarily in the cytoplasm of
Leydig cells. No positive staining was found when primary
antibodies were omitted (Fig. 4, inserts at a, d’).
Expression and localization of LHR, PKA, PLIN, HSL,
StAR, TSPO, HMGCS, and HMGCR in LCTs
In LCTs, varied expression of LHR, PKA, PLIN, HSL, StAR,
TSPO, HMGCS, and HMGCRwas observed when compared
to normal Leydig cells (Fig. 5 a, b).
The expression of LHR and PKAwas increased (p < 0.05
and p < 0.01, respectively) as well as that of HMGCS and
HMGCR (p < 0.001 and p < 0.05, respectively). In contrast,
PLIN and StAR expressions were decreased (p < 0.001 and
p < 0.05, respectively), while a non-significant increase was
observed for HSL and TSPO. Changes were also found for
mRNA LHR, PKA, PLIN, HSL, StAR, TSPO, HMGCS, and
HMGCR expressions in LCTs (Fig. 6).
In control Leydig cells, membrane cytoplasmic and LCT
cytoplasmic stainings of LHR were found (Fig. 7 a, a’).
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The immunostaining was of moderate intensity in control
Leydig cells but was weak and present in minority of cells of
LCTs. No differences were found in PKA distribution and im-
munostaining (Fig. 7 b, b’), with strong staining present in
control and tumor Leydig cell cytoplasm. PLIN distribution,
reflecting distribution of lipid droplets, was cytoplasmic in
control Leydig cells and LCTs (Fig. 7 c, c’). In control Leydig
cells, staining intensity was strong while found to be weak in
LCTs. Increased HSL staining intensity was detected in LCTs
when compared to control cells (Fig. 7 d, d’) and was exclu-
sively cytoplasmic. Strong immunoreaction was found in the














30 µm20 µm50 µm5 µm
Fig. 1 Morphology of human Leydig cell tumors—scanning electron
microscopic analysis (a A–F and b G–L). (A–D) General structure of
fragments of testicular biopsies used for analysis. (E, F) Fragments of
tissue with tumor. Note solid tumor structure with areas separated by
deep grooves. (E, F) and b (G, H) cellular masses infiltrating each
other. (I–L) Tumor Leydig cells in mass tightly linked by thick
projections formed a cage-like structure covering individual tumor
sheets. Representative microphotographs of scanning electron
microscopic analysis of human Leydig cell tumors (LCTs). Bars
represent 1 μm. For analysis, n = 12 specimens were used
Fig. 2 Morphology of human Leydig cell tumors—hematoxylin-eosin
staining representative microphotographs of (A) control human testis
and (B, b–b”’) Leydig cell tumors (LCTs). Scale bars represent 30 μm.
Staining was performed on serial testicular sections from n = 12
specimens. LC - Leydig cells; EC - epithelial cells of blood vessels.
(b)— cells of large polygonal shape with abundant, cytoplasm,
indistinct cell borders, and regular, round to oval nuclei (arrows).
Prominent nucleus visible at (b) higher magnification (arrowheads),
(b’)— cells with above features but possessing distinct cell borders and
smaller nuclei (arrows), (b”)— small cells with scant, densely
eosinophilic cytoplasm and grooved nuclei (arrow), (b”’)— spindle-
shaped (sarcomatoid) cells (arrow)
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intensity of StAR, exclusively present in the cytoplasm (as dif-
fuse signal indicating on distribution of mitochondria), was
observed in a few cells of LCTs (Fig. 7 e, e’) while control
Leydig cells exhibitedmoderate cytoplasmic staining. A similar
pattern was found for mitochondrial TSPO (Fig. 7 f, f’).
Moderate, diffused cytoplasmic expression was revealed in
control Leydig cell cytoplasm, while the TSPO staining inten-
sity was veryweak but still diffused in LCTs. However, in a few
cells, immunoreaction was very strong. No differences were
found in the distribution of HMGCS and HMGCR between
control cells and LCTs (Fig. 7 g, g’ and h, h’). Strong cytoplas-
mic expression of HMGCS and moderate cytoplasmic expres-
sion of HMGCR were revealed in control Leydig cells and
LCTs, respectively. No positive staining was found when pri-
mary antibodies were omitted (Fig. 7, inserts at a, f’).
Effect of GPER and PPAR blockage on expression
of PI3K, Akt, and mTOR in LCTs and mTOR in MA-10
cells
In LCTs, PI3K and Akt expressions were increased (p < 0.05)
while no changes inmTOR expression were found when com-
pared to controls (Fig. 8 a, b).
In MA-10 cells, expression of mTOR was decreased
(p < 0.001) after blockage of GPER or GPER together with
PPARγ (Fig. 8 c). Blockage of PPARα, PPARγ, or GPER
together with PPARγ increased (p < 0.05, p < 0.01,
p < 0.001) mTOR expression.
Effect of GPER and PPAR blockage on estradiol
secretion and cGMP concentration in MA-10 cells
Secretion of estradiol markedly increased (p< 0.001) after GPER
blockage (Fig. 9 a). A similar increase (p < 0.01) was observed
after GPER and PPARα blockage. Conversely, blockage of
GPER and PPARγ decreased (p < 0.05) estradiol secretion.
When either PPARα or PPARγ was blocked, no to little alter-
ations (p< 0.05) in hormone secretion were revealed.
Changes in cGMP concentration after antagonist-treatment
were similar to those of estradiol secretion (Fig. 9 b).
Treatment with a GPER antagonist, alone or in combination
with a PPARα antagonist, increased (p < 0.05, p < 0.01)
cGMP concentration while treatment with PPARα or γ antag-
onists consistently decreased (p < 0.05) the concentration.
Only treatment with GPER and PPARγ antagonists in combi-
nation increased (p < 0.01) cGMP concentration.
Discussion
Benign LCTs are classically presented as a small (3–5 cm in
diameter), sharply delineated, and solid mass embedded within
the testis (Al-Agha and Axiotis 2007). Alternatively, malignant
LCTs are typically larger (greater than 5 cm in diameter), have
infiltrative margins, and show areas of hemorrhage and necrosis.
They replace the testis and/or extend beyond testicular parenchy-
ma. For the first time, we showed by scanning electron micro-
scope a complicated LCT cellular organization. We found that
Fig. 3 Expression of GPER, PPARα, PPARβ, and PPARγ in human
Leydig cell tumor. (a) Representative immunoblots of qualitative
expression of GPER, PPARα, and PPARγ and (b) relative expression
(quantitative representation after densitometry of data; arbitrary units).
The relative amount of respective proteins normalized to β-actin.
Relative intensity from three separate analyses is expressed as means ±
SD. Asterisks show significant differences between respective control
and Leydig cell tumor (LCTs). Values are denoted as ∗p < 0.05,
∗∗p < 0.01, and ∗∗∗p < 0.001. Analysis was performed in triplicate
(n = 7). (c) Relative level (relative quantification; RQ) of mRNA for
GPER, PPARα, PPARβ, and PPARγ determined using real-time RT-
PCR analysis 2−ΔCt method. As an intrinsic control, β-actin mRNA
level was measured in the samples. RQ from three separate analyses is
expressed as means ± SD. Asterisks show significant differences between
respective control and Leydig cell tumor (LCTs). Values are denoted as
∗p < 0.05 and ∗∗∗p < 0.001. Analysis was performed in triplicate (n = 7)
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individual cells were not recognized in the solid mass, but a
number of prolongations of various sizes were formed, maintain-
ing cells tightly linked to each other; however, this did not let to
distinguish benign and malignant tumors. Morphologically,
LCTs can consist predominantly of one type or as a mixture of
the four types of cells with abundant lipid accumulation
(Richmond et al. 1995). This is in agreement with our
observations. In addition, our immunohistochemical results of
StAR and PLIN may suggest that LCT cells are overloaded
with lipids that probably are not processed to mitochondria.
A central factor in LCT growth and progression is represent-
ed by an inadequate intratesticular balance in the androgen/
estrogen ratio with advantage of the latter hormone (Carreau
et al. 2010; Fowler et al. 2000; Sirianni et al. 2007). Varying
expression patterns of ERα and ERβ were observed in human
LCTs compared to healthy testis (Carpino et al. 2007). Also, in
human and rat LCTs, involvement of GPER in cell proliferation,
growth, and apoptosis was shown. Rago et al. (2009, 2011)
confirmed the presence of GPER in germ cell tumors and sex-
cord stromal tumors. However in LCTs, the authors found no
differences in GPER expression in relation to normal testis. In
contrast, herein, we revealed an increase in GPER expression in
LCTs. Also in our in vitro experiments in mouse tumor Leydig
cells, GPER expression was increased (Gorowska-Wojtowicz
et al. 2018). Taken together, it is likely that various estrogen
pathways may be deregulated in LCTs, which reflects tumor
heterogeneity and may contribute to its development.
Herein, we showed GPER, alone and together with PPARα,
effected estradiol secretion by tumor Leydig cells. Such result
indicates on a leading role of GPER in regulation of sex hormone
production and secretion and concomitantly suggests possible
GPER and PPARα alterations in LCTs. Similarly, our prior study
also showed progesterone secretion modulation in GPER and
PPAR antagonist-treated tumor mouse Leydig cells (Gorowska-
Wojtowicz et al. 2018). According to findings by Chimento et al.
(2011), GPER is a good target for reduction of tumor Leydig cell
proliferation that is hormonally controlled.
We showed, for the first time, a PPAR expression pattern in
normal human Leydig cells and its prominent downregulation in
LCT. An opposite correlation was found in dog testis, and PPAR
expression was always markedly higher in tumor tissue (Sozmen
et al. 2013). Notably, confusing results were seen concerning the
involvement of PPAR in tumor biology. PPAR was revealed to
both promote and inhibit cancer via effects on cell differentiation,
growth, metastasis, and lipid metabolism (Maan et al. 2018).
In our findings, both in vivo and in vitro studies revealed
possible relationship between GPER, PPAR, and lipid
homeostasis-controlling molecules in LCT. Recent studies
have linked lipid abundance with increased tumor aggressive-
ness and its resistance to chemotherapy (Tirinato et al. 2017).
Findings by Christian et al. (2013) showed that autophagy
influences lipid metabolism via both lipogenesis and lipolysis.
Lipid droplets may induce lipophagy to avoid lipotoxicity, a
phenomenon caused by excessive lipid accumulation with in-
volvement of the mTOR signaling pathway (Yang et al. 2018).
Increased cholesterol content without activated mTOR can be
Fig. 4 Localization of GPER, PPARα, PPARβ, and PPARγ in human
Leydig cell tumor. Representative microphotographs of cellular
localization of GPER (a, a’ and higher magnification at a’), PPARα (b,
b’ and highermagnification at b’), PPARβ (c, c’ and higher magnification
at c’), and PPARγ (d, d’ and higher magnification at d and d’) in control
human testes (a–d and higher magnification at d) and Leydig cell tumor
(LCTs). DAB immunostaining with hematoxylin counterstaining. Scale
bars represent 100 μm. Staining was performed on serial testicular
sections from n = 12 specimens. Arrows depict cytoplasmic staining;
arrowheads depict nuclear staining. No positive staining is seen when
the primary antibodies were omitted—insert at a and d’ (negative
controls)
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Fig. 5 Expression of LHR, PKA, PLIN, HSL, StAR, TSPO, HMGCS,
and HMGCR in human Leydig cell tumor. (a) Representative blots of
qualitative expression of LHR, PKA, PLIN, HSL, PLIN, StAR, TSPO,
HMGCS, and HMGCR and (b) relative expression (quantitative
representation after densitometry of data; arbitrary units). The relative
amount of respective proteins normalized to β-actin. Relative intensity
from three separate analyses is expressed as means ± SD. Asterisks show
significant differences between respective control and Leydig cell tumor
(LCTs). Values are denoted as ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗p < 0.001.
Analysis was performed in triplicate (n = 7)
Fig. 6 Expression of mRNA for LHR, PKA, PLIN, HSL, StAR, TSPO,
HMGCS, and HMGCR in human Leydig cell tumor. Relative level
(relative quantification; RQ) of mRNA for LHR, PKA, PLIN, HSL,
PLIN, StAR, TSPO, HMGCS, and HMGCR determined using real-time
RT-PCR analysis 2−ΔCt method. As an intrinsic control, β-actinmRNA
level was measured in the samples. RQ from three separate analyses is
expressed as means ± SD. Asterisks show significant differences between
respective control and Leydig cell tumor (LCTs). Values are denoted as
∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. Analysis was performed in
triplicate (n = 7)
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an indirect result of lipophagy and/or PLIN alterations in
LCTs. It seems this particular tumor can have a distinct biol-
ogy, but it is possible that some mechanisms may be induced
later when its development is more advanced. Last data dem-
onstrate that lipophagy contributes to testosterone biosynthe-
sis at least partially through degrading lipid droplets and cho-
lesterol content (Ma et al. 2018). In steroidogenic cells, the
mechanism underlying lipid turnover and receptor involve-
ment remained unrevealed (Maizlin et al. 2004); however,
based on our results, GPER-PPAR cross-talk should be taken
into consideration.
We found prominent changes in LHR, StAR, and PKA ex-
pressions, reflecting disturbances in lipid controllingmechanisms
directly associatedwith central endocrine regulation and the local
microenvironment. In LCT, we detected decreased expression of
StAR and increased expression of LHR. In contrary, in tumor
mouse Leydig cell line (mLTC-1), StAR activity was increased
while LHR expression was significantly reduced (Manna et al.
2007). These discrepancies may be due to species specific char-
acteristics of tumor Leydig cells or may be ascribed to above-
mentioned tumor heterogeneity or complex mechanisms regulat-
ing protein biology (Bauer et al. 2015). Nevertheless, the
Fig. 7 Localization of LHR, PKA, PLIN, HSL, StAR, TSPO, HMGCS,
and HMGCR in human Leydig cell tumor. Representative
microphotographs of cellular localization of LHR (a–a’), PKA (b–b’),
PLIN (c–c’ and higher magnifications at c and c’), HSL (d–d’), StAR
(e–e’), TSPO (f–f’), HMGCS (g–g’), and HMGCR (h–h’) in control
human testes (a–h and higher magnification at c) and Leydig cell tumor
(a’–h’ and higher magnification at c’). DAB immunostaining with
hematoxylin counterstaining. Scale bars represent 100 μm. Staining
was performed on serial testicular sections from n = 12 specimens.
Arrows depict cytoplasmic staining. Arrowheads depict strong stained
cells for TSPO and positively stained epithelial cells of blood vessels
for HSL. No positive staining is seen when the primary antibodies were
omitted—insert at a and f’ (negative controls)
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regulation of steroidogenesis is clearly disturbed in LCT.
Moreover, in our study, LHR was found in the cytoplasm as this
receptor can be internalized. Internalization is a part of the phys-
iological mechanism of action for manyG-coupled receptors in a
specific condition, e.g., agonist treatment, influence of tissue/cell
microenvironment (Reubi 2014). In pathological conditions,
translocation of proteins is usually observed phenomenon.
Perturbations in StAR expression patterns observed in
the present study may reflect altered mitochondrial func-
tion and/or degradation (mitophagy), thus affecting lipid
homoeostasis in TLCs (Barbosa and Siniossoglou 2017).
Herein, HSL and TSPO expressions did not vary in
LCTs, suggesting a subordinate role of these molecules
in LCTs.
Fig. 8 Expression of PI3K-Akt-mTOR pathway in human Leydig cell
tumor. (a) Representative blots of qualitative expression of PI3K, Akt,
mTOR, and (b) relative expression (quantitative representative after
densitometry of data; arbitrary units). The relative amount of respective
proteins normalized to β-actin. Relative intensity from three separate
analyses is expressed as means ± SD. Asterisks show significant differences
between control and Leydig cell tumor (LCTs). Values are denoted as
∗p< 0.05. Analysis was performed in triplicate (n= 7). (c) Effect of GPER
and PPAR blockage on expression of mTOR inMA-10 cells. Representative
blots of qualitative expression of mTOR and relative expression (quantitative
representation after densitometry of data; arbitrary units). The relative amount
of protein normalized to β-actin. Relative intensity from three separate
analyses is expressed as means ± SD. Asterisks show significant differences
between control and treated Leydig cells. Values are denoted as ∗p< 0.05,
∗∗p< 0.01, and ∗∗∗p< 0.001. Analysis was performed in triplicate (n= 3 for
each experimental group)
Fig. 9 Effect of GPER and PPAR blockage on expression on estradiol
secretion and cGMP concentration inMA-10 cells. Estradiol secretion (a)
and cGMP concentration (b) in control and treated with GPER (10 nM),
PPARα (10 μM) and PPARγ (μM) antagonists alone or in combinations
for 24 h tumor mouse Leydig cells (MA-10). Asterisks show significant
differences between control and treated Leydig cells. Values are denoted
as ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. Analysis was performed in
triplicate (n = 3 for each experimental group)
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Lipid droplet associated proteins are actively involved in
modulating lipid homeostasis by generating sites for steroido-
genic enzyme activity (Shen et al. 2016). Changes in PLIN
expression found in our study may suggest that in LCT not
only transport of cholesterol to mitochondria but also lipid
storage and mobilization from lipid droplets are dysregulated.
This may be considered as additional factor aiding in the de-
velopment of LCTs.
Enhanced expression of sterol regulatory element bind-
ing proteins (SREBPs), involved in cholesterol and fatty
acids synthesis through the Akt pathway (anchored-lipid
membrane protein), correlates with tumor development,
progression, and invasiveness, as well as increased lipid
content in cell membranes (Beloribi-Djefaflia et al. 2016).
Through both the post-translational regulation and induc-
tion of transcriptional programs, the dysregulated PI3K-
Akt-mTOR pathway coordinates the uptake and utilization
of multiple nutrient lipids supporting the enhanced growth
and proliferation of cancer cells (Basharat et al. 2016). In
this study, we found PI3K, Akt, and mTOR signaling al-
terations, which indicate that also LCT deregulation of
these pathways may be an important event accompanying
tumor development. Notably, changes in hormonal milieu
including estradiol can result in modulation and mTOR
activity (Blagosklonny 2010). Our earlier studies in mouse
tumor Leydig cells revealed that GPER and PPAR inhibi-
tions activated PI3K and Akt (Gorowska-Wojtowicz et al.
2018). Here we showed that in addition, mTOR was mod-
ulated diversely dependently on receptor antagonist used
alone or in combination, inhibited by GPER antagonist
alone and together with PPARγ antagonist as well as acti-
vated by GPER with PPARα together and the latter alone.
Therefore, these results demonstrated that GPER- and
PPARα-mediated pathways are involved in the mainte-
nance of mTOR activity, whereas PPARγ signaling has
an opposite effect, reducing mTOR activity.
Distinct changes in cGMP level suggest GPER-PPAR–me-
diated high or only via PPAR low metastatic activity of LCT.
cGMP agonist was confirmed as a mediator of lipolysis in
oocytes (Mendoza et al. 2011). In LCTs, cGMP seems to be
important in maintaining lipid homeostasis when GPER and
PPAR are absent.
The outcome of lipid content modification is a result of
various protein–protein cross-talk that was revealed here also
betweenGPER-PPAR and HMGCS and HMGCR resulting in
overexpression of the latter enzymes that is in line with our
earlier in vitro study (Gorowska-Wojtowicz et al. 2018).
HMGCS/HMGCR implications in cancer cell proliferation
and cooperation with Ras signaling are currently used in
cholesterol-lowering drug therapy (Schwarz et al. 2018).
According to Ding et al. (2008), HMGCR is an important
marker for tumor testis transformation in mice.
Conclusion
Mechanisms concerning Leydig cell tumorigenesis are scarcely
known, and the role of lipid metabolism in tumor cells has long
been disregarded. Very recently, it was suggested that knowing
reprogramming of metabolic mechanisms in tumor can be used
as prominent future target of therapy (Sreedhar and Zhao 2018).
We presented here, for the first time, alterations in lipid- and
cholesterol-associated proteins and one possible mechanisms of
action of these molecules in LCT, which concomitantly may be
primary disturbances in healthy Leydig cell. Further studies are
needed to elucidate the type, role, and regulation of lipids syn-
thesized in tumors of steroidogenic cells. Our findings shed light
on the novel functional interplay between GPER and PPAR ul-
timately probably controlling and/or affecting lipid metabolism
and steroidogenesis in LCTs. Modifications of expression of
LHR, PKA, PLIN, HSL, StAR, TSPO, HMGCS, and
HMGCR, together with cGMP and PI3K-Akt-mTOR pathways,
may be suitable in developing innovating approaches (combined
with transcriptome/proteome analyses and lipidomic data) that
target pathological processes of Leydig cells. There is an urgent
need for additional experimental and clinical data to complete the
current knowledge on the biology and molecular characteristics
of LCTs that will guide the early diagnostics, treatment, and
surveillance of incoming patients with this disease. Another im-
portant issue is elaboration of experimental model that we are
currently working on (Gorowska-Wojtowicz et al. 2019) includ-
ing those more accurately reflecting human tumor, e.g., human
tumor Leydig cell lines and human tumor xenografts.
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